SBU should investigate what is an evidence-based and cost-effective use of statins;SBU bör utreda vad som ar en evidensbaserad och kostnadseffektiv statinanvändning.

Läkartidningen

Volumn 106, Issue 32-33, 2009, Pages 1992-1994

  Hjemdahl, Paul ^a   Allhammar, Anette ^a   Heaton, Claire ^a   Hulting, Johan ^a   Kahan, Thomas ^a   Malmström, Rickard ^a   Martinsson, Arne ^a   Rücker, Franz ^a   Schenck Gustafsson, Karin ^a   Schwieler, Jonas ^a   Törnerud, Mattias ^a   Wettermark, Björn ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; SIMVASTATIN;

ARTICLE; CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; DRUG UTILIZATION; ECONOMICS; EVIDENCE BASED MEDICINE; HUMAN; SWEDEN;

ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; SIMVASTATIN; SWEDEN;

EID: 70349307208     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)